1Spencer, BWJ, Shields, G, Gergel, T, Hotopf, M, Owen, GS. Diversity or disarray? A systematic review of decision-making capacity for treatment and research in schizophrenia and other non-affective psychoses. Psychol Med 2017; 47: 1906–22.
2The Schizophrenia Commission. The Abandoned Illness: a Report from the Schizophrenia Commission. The Schizophrenia Commission, 2012.
3Riedel, M, Strassnig, M, Muller, N, Zwack, P, Moller, HJ. How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? Eur Arch Psychiatry Clin Neurosci 2005; 255: 143–8.
4Hofer, A, Hummer, M, Huber, R, Kurz, M, Walch, T, Fleischhacker, WW. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol 2000; 20: 699–702.
5World Medical Association. World Medical Association Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. World Medical Association, 2013.
6Owen, GS, Richardson, G, David, AS, Szmukler, G, Hayward, P, Hotopf, M. Mental capacity to make decisions on treatment in people admitted to psychiatric hospitals: cross sectional study. BMJ 2008; 337: a448.
7Mental Capacity Act 2005. England and Wales.
8Grisso, T, Appelbaum, PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. Oxford University Press, 1998.
9Casey, PR, Kelly, B. Fish's Clinical Psychopathology: Signs and Symptoms in Psychiatry (3rd edn). Gaskell, 2007.
10Cowen, P, Harrison, PJ, Burns, T. Shorter Oxford Textbook of Psychiatry (6th edn). Oxford University Press, 2012.
11Kay, SR, Fiszbein, A, Opler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–76.
12Owen, GS, Freyenhagen, F, Hotopf, M, Martin, W. Temporal inabilities and decision-making capacity in depression. Phenomenol Cogn Sci 2013; 14: 163–82.
13World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, 1993.
14American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV (4th edn). American Psychiatric Association, 1994.
16Appelbaum, PS, Roth, LH, Lidz, C. The therapeutic misconception: informed consent in psychiatric research. Int J Law psychiatry 1982; 5: 319–29.
17Appelbaum, PS, Grisso, T. MacCAT-CR MacArthur Competence Assessment Tool for Clinical Research. Professional Resource Press, 2001.
18Cairns, R, Maddock, C, Buchanan, A, David, AS, Hayward, P, Richardson, G, et al. Reliability of mental capacity assessments in psychiatric in-patients. Br J Psychiatry 2005; 187: 372–8.
19Kim, SY, Appelbaum, PS, Kim, HM, Wall, IF, Bourgeois, JA, Frankel, B, et al. Variability of judgments of capacity: experience of capacity evaluators in a study of research consent capacity. Psychosomatics 2011; 52: 346–53.
20Grisso, T, Appelbaum, PS, Hill-Fotouhi, C. The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv 1997; 48: 1415–9.
21Craddock, M, Asherson, P, Owen, MJ, Williams, J, McGuffin, P, Farmer, AE. Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br J Psychiatry 1996; 169: 58–63.
22Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–35.
23Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
24Wing, JK, Beevor, AS, Curtis, RH, Park, SB, Hadden, S, Burns, A. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry 1998; 172: 11–8.
25Guy, W. ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub. (ADM): 218–22. U.S. National Institute for Mental Health, 1976.
26Gladsjo, JA, Schuman, CC, Evans, JD, Peavy, GM, Miller, SW, Heaton, RK. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment 1999; 6: 147–78.
27Wechsler, D. Wechsler Adult Intelligence Scale (3rd edn). The Psychological Corporation, 1997.
28Heaton, RK, Miller, SW, Taylor, MJ, Grant, I. Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults. Psychological Assessment Resources, 2004.
29Reitan, RM, Wolfson, D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation (2nd edn). Neuropsychological Press, 1993.
30Cuesta, MJ, Pino, O, Guilera, G, Rojo, JE, Gómez-Benito, J, Purdon, SE, et al. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP). Schizophr Res 2011; 130: 137–42.
31Palmer, BW, Jeste, DV. Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia. Schizophr Bull 2006; 32: 98–106.
32David, AS, Bedford, N, Wiffen, B, Gilleen, J. Failures of metacognition and lack of insight in neuropsychiatric disorders. Philos Trans R Soc Lond B Biol Sci 2012; 367: 1379–90.
33Dunn, LB, Lindamer, LA, Palmer, BW, Golshan, S, Schneiderman, LJ, Jeste, DV. Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. Am J Geriatr Psychiatry 2002; 10: 142–50.
34Jeste, DV, Palmer, BW, Golshan, S, Eyler, LT, Dunn, LB, Meeks, T, et al. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophr Bull 2009; 35: 719–29.